Related Experiment Video
Updated: Dec 20, 2025
A Cell Culture Model for Producing High Titer Hepatitis E Virus Stocks
Published on: June 26, 2020
Ethical and Practical Issues Associated With the Possibility of Using Controlled Human Infection Trials in Developing
Andrea Cox1,2, Mark Sulkowski1, Jeremy Sugarman1,2,3
1School of Medicine, Johns Hopkins University, Baltimore, Maryland, USA.
Abstract:
Despite the existence of established treatments for hepatitis C virus (HCV), more effective means of preventing infection, such as a vaccine, are arguably needed to help reduce substantial global morbidity and mortality. Given the expected challenges of developing such a vaccine among those at heightened risk of infection, controlled human infection studies seem to be a promising potential approach to HCV vaccine development, but they raise substantial ethical and practical concerns. In this article, we describe some of the challenges related to the possibility of using controlled human infection studies to accelerate HCV vaccine development. The related ethical and practical concerns require further deliberation before such studies are planned and implemented.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
01:15Bioavailability Study Design: Healthy Subjects Versus Patients
01:11Clinical Trials: Overview